- Home
- NIXX vs RGLS Comparison
NIXX vs RGLS Comparison
Compare NIXX & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- RGLS
- Stock Information
- Founded
- NIXX 2010
- RGLS 2007
- Country
- NIXX United States
- RGLS United States
- Employees
- NIXX N/A
- RGLS N/A
- Industry
- NIXX
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- NIXX
- RGLS Health Care
- Exchange
- NIXX NYSE
- RGLS Nasdaq
- Market Cap
- NIXX 66.8M
- RGLS 74.0M
- IPO Year
- NIXX N/A
- RGLS 2012
- Fundamental
- Price
- NIXX $1.96
- RGLS $1.31
- Analyst Decision
- NIXX
- RGLS Strong Buy
- Analyst Count
- NIXX 0
- RGLS 6
- Target Price
- NIXX N/A
- RGLS $10.33
- AVG Volume (30 Days)
- NIXX 213.0K
- RGLS 820.1K
- Earning Date
- NIXX 04-15-2025
- RGLS 03-20-2025
- Dividend Yield
- NIXX N/A
- RGLS N/A
- EPS Growth
- NIXX N/A
- RGLS N/A
- EPS
- NIXX N/A
- RGLS N/A
- Revenue
- NIXX $668,693.00
- RGLS N/A
- Revenue This Year
- NIXX $209.13
- RGLS N/A
- Revenue Next Year
- NIXX N/A
- RGLS N/A
- P/E Ratio
- NIXX N/A
- RGLS N/A
- Revenue Growth
- NIXX N/A
- RGLS N/A
- 52 Week Low
- NIXX $1.20
- RGLS $0.83
- 52 Week High
- NIXX $8.50
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- RGLS 53.78
- Support Level
- NIXX N/A
- RGLS $1.22
- Resistance Level
- NIXX N/A
- RGLS $1.60
- Average True Range (ATR)
- NIXX 0.00
- RGLS 0.13
- MACD
- NIXX 0.00
- RGLS 0.03
- Stochastic Oscillator
- NIXX 0.00
- RGLS 50.85
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.